Cipher Pharmaceuticals Inc T.CPH

Alternate Symbol(s): CPHRF

Healthcare

Cipher Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products either directly in Canada or indirectly through partners in Canada, the United States and South America. Its Dermatology products include Actikerall, Epuris, Ozanex and Vaniqa. Its Hospital Acute Care products include Aggrastat and Brinavess. Its Out-Licensed products include Absorica, ConZip and Lipofen. The Company is also focused on building a portfolio of prescription medicines that serve unmet medical needs. The Company's product pipeline development programs including MOB-015, DTR-001, and CF-101. The Company's subsidiaries include Cipher US Holdings Inc., Cipher US Holdco LLC, and Cipher Pharmaceuticals US LLC.

TSX:CPH - Post by User

Cipher Pharmaceuticals Inc

Bullboard Posts

Comment by ok2buyon Apr 22, 2019 4:03pm

78 Views

Post# 29656079

RE:Bouncing Around 52 week Low

ok2buy wrote: Stock is bouncing around its' 52 week low today but still not easy to get shares. Had my bid in @ $1.24, still no fill. $1.25 on the ask won't budge./

Filled my order near close, stock then got pushed lower right at close down to $1.23 (the day's low) on a 100 share fill. The games are afoot here. LOL./

Bullboard Posts

Fortune Minerals receives funding for NICO project development